Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition0On 2017-03-302017-07-04By Bioinformatics Solutions IncIn User PublicationsRiedemann, N.C., et al. Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition. Clinical Immunology. 30/3/2017.